Clinical Trial Update: Evaluate the Efficacy and Safety of XKH001 Injection in Patients With Moderate-to-Severe Atopic Dermatitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is planned to evaluate the efficacy and safety of XKH001 Injection for moderate-to-severe atopic dermatitis; the study status is NOT_YE…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• XKH001 Injection

Snippet

Sponsor: Zhejiang Kanova Biopharmaceutical Co., LTD | Conditions: Atopic Dermatitis | Phase 2 | Status: NOT_YET_RECRUITING